Trial Profile
A Study to Evaluate the Dose Equivalence of Incobotulinumtoxin A and Onabotulinumtoxin A for the Treatment of Moderate-to-Severe Glabellar Frown Lines (GFL)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Feb 2016
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Glabellar lines
- Focus Therapeutic Use
- 17 Feb 2016 New trial record